MSN Labs Europe Limited Pharmadox Healthcare Limited

This medicine is intended for adult men with prostate cancer that has metastasized to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.

Dosage form: tablets, film-coated

ATC: L02BX03

The medicine is used in adult men for the treatment of prostate cancer that has spread to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.

Dosage form: tablets, film-coated

ATC: L02BX03

The medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission).

Dosage form: tablets, film-coated

ATC: L01BC07

The medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission).

Dosage form: tablets, film-coated

ATC: L01BC07

The medicine is used in adults for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These are bone marrow diseases that make it difficult to produce blood cells correctly.

Dosage form: powder for preparation of injection suspension

ATC: L01BC07

The medicine is used to relieve the symptoms of hay fever (such as sneezing, runny nose, nasal congestion, itching, and red, watery eyes) and other forms of allergic rhinitis. It also helps in the treatment of itchy skin rashes (urticaria).

Dosage form: tablets

ATC: R06AX29

It is used in adults as well as in children and adolescents over 6 years of age with Ph-positive chronic myeloid leukemia. It may be used in cases of newly diagnosed disease or when previous treatment has not been effective. The medicine is also used in the accelerated phase and the blast crisis phase of this leukemia.

Dosage form: tablets, film-coated

ATC: L01EA04

This medicine is used in adults as well as in children and adolescents over 6 years of age with Ph-positive chronic myeloid leukemia. It may be used in newly diagnosed disease or when previous treatment has not been effective. It is also used in patients in the accelerated phase or the blast crisis phase.

Dosage form: tablets, film-coated

ATC: L01EA04

The medicine is used in adults and children and adolescents (over 6 years of age) suffering from Ph-positive chronic myeloid leukemia. It is intended for individuals in whom the disease has been newly diagnosed or in whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC: L01EA04

The medicine is used in adults to prevent the formation of blood clots in the arteries, which can lead to stroke, heart attack, or death. It is prescribed to people with atherosclerosis.

Dosage form: tablets, film-coated

ATC: B01AC30

This medicine is used to treat relapsing-remitting multiple sclerosis in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord, which may slow the progression of the disease.

Dosage form: capsules, hard, intestinal

ATC: L04AX07

This medicine is used to treat relapsing-remitting multiple sclerosis in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord, which may slow the progression of the disease.

Dosage form: capsules, hard, intestinal

ATC: L04AX07

The medicine is used in adult patients with type 2 diabetes when diet and physical exercise are not sufficient to control blood sugar levels. It helps to increase insulin production and decrease glucagon secretion.

Dosage form: tablets

ATC: A10BH02

The medicine is intended for adult patients with type 2 diabetes (non-insulin-dependent diabetes) for whom diet and physical exercise are not sufficient to control blood sugar levels.

Dosage form: tablets, film-coated

ATC: A10BD08

The medicine is used in adult patients with type 2 diabetes (insulin-independent) when diet and exercise are not sufficient to control the disease, or when it is administered together with other medicines, e.g., insulin.

Dosage form: tablets, film-coated

ATC: A10BD08

This medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Dosage form: tablets, film-coated

ATC: B01AF01

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

Dosage form: tablets, film-coated

ATC: B01AF01

Diwleiz is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing over 30 kg), it is also used to treat blood clots in the veins and lungs following initial treatment with injections.

Dosage form: tablets, film-coated

ATC: B01AF01

Diwleiz is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing over 30 kg), it is also used to treat blood clots in the veins or lungs following initial injectable treatment.

Dosage form: tablets, film-coated

ATC: B01AF01

The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

Dosage form: tablets, film-coated

ATC: B02BX05

The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.

Dosage form: tablets, film-coated

ATC: B02BX05

This medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (ITP) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C who have a low platelet count.

Dosage form: tablets, film-coated

ATC: B02BX05

The medicine is used to lower elevated cholesterol (total and 'bad' LDL cholesterol) and triglycerides in the blood, and also increases the level of 'good' cholesterol (HDL). It is used when diet alone is not sufficient to control cholesterol levels.

Dosage form: tablets

ATC: C10AX09

The medicine is used in adults who had a heart attack more than a year ago. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.

Dosage form: tablets, film-coated

ATC: B01AC24

The medicine is used in adults who have experienced a heart attack or unstable angina. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.

Dosage form: tablets, film-coated

ATC: B01AC24

The medicine is intended for adults with type 2 diabetes who have not been able to control their blood sugar levels through diet, exercise, or a single antidiabetic drug (metformin or sulfonylurea derivatives) alone.

Dosage form: tablets, film-coated

ATC: A10BH05

The medicine is used to prevent and treat many types of fungal infections. In adults, it is used to treat infections caused by fungi of the genera Aspergillus, Fusarium, and Coccidioides, as well as diseases such as chromoblastomycosis and maduromycosis. It may also be used prophylactically in individuals at high risk of infection, e.g., in patients with a weakened immune system following chemotherapy or after hematopoietic stem cell transplantation.

Dosage form: tablets, enteric-coated

ATC: J02AC04

The medicine is used in adults to prevent the formation of blood clots in the arteries, which can lead to serious complications such as stroke, heart attack, or death.

Dosage form: tablets, film-coated

ATC: B01AC30

The medicine is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) that were administered during anesthesia.

Dosage form: solution for injection

ATC: V03AB35

The medicine is used to prepare patients (adults, children, and adolescents) for a bone marrow transplant. It works by destroying bone marrow cells, which enables the introduction of new stem cells and the production of healthy blood cells.

Dosage form: powder for preparation of concentrate for infusion solution

ATC: L01AC01

The medicine is used to prepare the patient for a bone marrow transplant. It works by destroying bone marrow cells, which enables the transplantation of new stem cells and the production of healthy blood cells by the body.

Dosage form: powder for preparation of concentrate for infusion solution

ATC: L01AC01

The medicine is used in adults to prevent the formation of blood clots (e.g., after hip or knee surgery and in people with atrial fibrillation) and to treat thrombosis of the leg veins and pulmonary vessels. It is also used in children and adolescents for the treatment and prevention of clots in the veins or lungs.

Dosage form: tablets, film-coated

ATC: B01AF02

The medicine is used in adults to prevent the formation of blood clots in the heart (in people with atrial fibrillation) and in the treatment and prevention of recurrence of clots in the veins of the legs or pulmonary vessels. In children and adolescents (from 28 days to 18 years), it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

Dosage form: tablets, film-coated

ATC: B01AF02